J05AR Antivirals for treatment of HIV infections, combinations
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05AR Antivirals for treatment of HIV infections, combinations
Medicines by ATC code J05AR Antivirals for treatment of HIV infections, combinations
- Juluca Patient leaflet Summary of medicine characteristics
- Evotaz Patient leaflet Summary of medicine characteristics
- Lopinavir/Ritonavir Mylan Patient leaflet Summary of medicine characteristics
- Atripla Patient leaflet Summary of medicine characteristics
- Efavirenz/Emtricitabine/Tenofovir disoproxil Krka Patient leaflet Summary of medicine characteristics
- Trizivir Patient leaflet Summary of medicine characteristics
- Kivexa Patient leaflet Summary of medicine characteristics
- Combivir Patient leaflet Summary of medicine characteristics
- Lamivudine/Zidovudine Teva Patient leaflet Summary of medicine characteristics
- Emtricitabine/Tenofovir disoproxil Mylan Patient leaflet Summary of medicine characteristics
- Biktarvy Patient leaflet Summary of medicine characteristics
- Triumeq Patient leaflet Summary of medicine characteristics
- Dovato Patient leaflet Summary of medicine characteristics
- Emtricitabine/Tenofovir disoproxil Krka Patient leaflet Summary of medicine characteristics
- Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan Patient leaflet Summary of medicine characteristics
- Stribild Patient leaflet Summary of medicine characteristics
- Genvoya Patient leaflet Summary of medicine characteristics
- Delstrigo Patient leaflet Summary of medicine characteristics
- Eviplera Patient leaflet Summary of medicine characteristics
- Emtricitabine/Tenofovir disoproxil Zentiva Patient leaflet Summary of medicine characteristics
- Descovy Patient leaflet Summary of medicine characteristics
- Odefsey Patient leaflet Summary of medicine characteristics
- Truvada Patient leaflet Summary of medicine characteristics
- Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva Patient leaflet Summary of medicine characteristics
- Kaletra Patient leaflet Summary of medicine characteristics
- Emtricitabine/Tenofovir disoproxil Krka d.d. Patient leaflet Summary of medicine characteristics
- Dutrebis Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: J05AR Antivirotika k léčbě infekce HIV, kombinace
- French: J05AR antiviraux utilisés en association pour le traitement des infections à vih
- German: J05AR Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen
- German: J05AR Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen
- Italian: J05AR Antivirali per il trattamento dell'infezione da HIV associazioni ( Compatibilmente con le esigenze cliniche del paziente, privilegiare il farmaco con un rapporto costo/efficacia più favorevole)
- Polish: J05AR Leki przeciwwirusowe do leczenia zakażenia HIV, kombinacje
- Turkish: J05AR HIV enfeksiyonlarının tedavisi için antiviraller, kombinasyonlar
- Portuguese (Brazil): J05AR Anti-víricos para o tratamento de infecções por VIH, associações